The Carlyle Group
Carlyle to invest $200m in Korea's Kakao Mobility
The Carlyle Group has invested $200 million in Kakao Mobility, a transportation-focused spinout from Korea’s Kakao Corporation that offers taxi-hailing, designated driver, and other services.
Carlyle abandons pursuit of Japan Asia Group
The Carlyle Group and the chairman of Japan Asia Group (JAG) have abandoned their bid for the company after a tender offer failed to generate sufficient shareholder support.
Carlyle, Brighton Park invest $200m in India's Indegene
The Carlyle Group and US GP Brighton Park Capital have committed a combined $200 million to Indegene, an Indian technology provider for the healthcare and life sciences industries.
AVCJ Awards 2020: Exit of the Year - IPO: SBI Card
The Carlyle Group helps SBI Card win its place in the ongoing rise of digital India before realizing a landmark domestic IPO. Coordination with State Bank of India has been crucial
AVCJ Awards 2020: Fundraising of the Year - Large Cap: The Carlyle Group
With twice as much dry powder as in its previous Japan vintage, The Carlyle group expects mega-deals and private equity participation to increase
Carlyle-backed consortium sweetens offer for Japan Asia Group
The Carlyle Group and the chairman of Japan Asia Group (JAG) have doubled the size of their tender offer for the Tokyo-listed company following pressure from an activist investor. The chairman is contributing most of the additional equity.
COVID-19 changing conduct as much as tech usage
Experiences vary across geographies as Asian GPs adapt to pandemic working conditions. Technology use is up, but the most lasting changes may be more cultural in nature.
Carlyle faces activist challenge to Japan Asia Group deal
An investment firm with ties to renowned Japanese activist investor Yoshiaki Murakami is challenging The Carlyle Group’s JPY37 ($355 million) bid for Japan Asia Group by launching a tender offer of its own.
Carlyle leads $123m Series D for China's Abbisko
The Carlyle Group - investing through its Asia growth fund - has led a $123 million Series D round for Chinese cancer-focused biotech developer Abbisko Therapeutics.
Carlyle buys Japanese X-ray equipment maker
The Carlyle Group has acquired a majority stake in Rigaku Corporation, a Japanese manufacturer of X-ray equipment, for an enterprise valuation of approximately JPY100 billion ($970 million).
PE-backed Perfect Diary jumps 75% on debut after $616m IPO
Yatsen Holding, the parent company of Chinese cosmetics brand Perfect Diary, gained 75% on its first day of trading on the New York Stock Exchange following a $616.9 million IPO.
COVID-19 amplifies focus on societal issues - AVCJ Forum
Concerns that impact investment would get pushed to the margins in the chaos of COVID-19 have been confounded by a renewed emphasis on social issues created by the pandemic, according to industry participants.
Q&A: The Carlyle Group's Kewsong Lee
Kewsong Lee, CEO of The Carlyle Group, discusses the firm’s response to COVID-19, finding alpha in a low growth world, not allowing size to inhibit speed of action, and embracing work-from-home
Carlyle targets Japan environmental business buyout - update
The Carlyle Group has launched a JPY37 billion ($355 million) buyout offer that would see it take control of Japan Asia Group, the Tokyo-listed holding company for several Japanese environment-related businesses, and two key subsidiaries.
Regulators halt Ant Group's Shanghai, Hong Kong IPO
Private equity-backed Ant Group’s bumper IPO in Hong Kong and Shanghai has been put on hold by Chinese regulators over a potential failure to meet listing qualifications or disclosure requirements.
Ex-CEO of India's HDFC Bank takes advisory role at Carlyle
Aditya Puri, previously CEO of HDFC Bank, India’s largest private sector lender, has joined The Carlyle Group as a senior advisor in Asia.
Carlyle Asia fund supports $2.3b Siemens carve-out
The Carlyle Group’s Asia buyout fund has joined its European counterpart in the EUR2 billion ($2.3 billion) acquisition of Flender, a Siemens subsidiary that manufactures mechanical and electrical drive systems commonly used in wind turbines and industrial...
Australia's Link Group rejects PEP, Carlyle buyout offer
Australia-based financial data and fund administration services provider Link Group has rejected a A$2.7 billion ($1.97 billion) buyout offer from Pacific Equity Partners (PEP) and The Carlyle Group, saying it materially undervalues the company.
Tencent leads $100m round for China education platform
Huohua Siwei, a China-based children's online education platform specializing in mathematics and science, has raised $100 million in the second tranche of the Series E round.
PE & Asian banks: Once-in-a-decade opportunity
GPs like targeting banks during downturns, investing in stronger players at discount valuations and backing them to come out the other side with increased market share. Will it be more of the same with COVID-19?
China rebound favors the few - AVCJ Forum
China’s economy has rebounded from COVID-19 faster than most others, but the pandemic has exposed a widening wealth gap in the country, industry participants told the AVCJ China Forum.
Deal focus: Affinity, Baring leverage market dislocation
Seeing Korean banks trading at discounted valuations and believing in the long-term health of the industry, some private equity investors have taken the opportunity to buy in the public markets
Carlyle invests $260m in China's Salubris Pharmaceutical
The Carlyle Group has paid about $260 million for a 5% stake in Shenzhen-listed Salubris Pharmaceutical.
PE-backed Ant Group files for Hong Kong, Shanghai IPO
Ant Group, the financial technology affiliate of China’s Alibaba Group, which has raised more than $20 billion in external private funding, has filed for a dual listing in Hong Kong and Shanghai.